Dysregulation of glutathione-S-transferase M3 (GSTM3) has been related to clear cell renal cell carcinoma (ccRCC) in our former study. GSTM3 plays a pivotal role of detoxification and clearance of reactive oxygen species (ROS) in tumour tissues. This study aimed to examine: (1) the associations between GSTM3 single nucleotide polymorphisms (SNPs) and risk of ccRCC, and (2) the potential molecular mechanism accounting for its effects. Clear cell renal cell carcinoma (ccRCC) is the major histological subtype (~80%). The incidence of RCC continued to rise over the past 2 decades. 1 It is 2-fold higher in men than in women. Surgical resection remains the main curative treatment. In the acknowledge of RCC therapy, it does not respond to radiotherapy and chemotherapy effectively, but responds to targeted therapies partially. Although the application of targeted therapies for RCC is promising, but there are
many problems of these novel strategies. 2 Little is known about the advancement of specific prognostic or risk molecular markers for RCC.
Recent genome-wide association studies (GWAS) indicated that several loci mapped on 2p21, 2q22.3, 11q13.3, 12p11.23 and 12q24.31 were associated with RCC risk significantly. [3] [4] [5] However, the genetic risk factor identified in Caucasian population is not so consistent with that in Asian population. 6 The causal genetic factors for RCC are still unclear.
In our previous study, we have screened the differentiated genes between metastasis and primary ccRCC cells using cDNA microarray.
Glutathione-S-transferase Mu3 (GSTM3), a GSTM-class subunit, was identified as a notably down-regulated gene. It both down-regulated in metastatic vs primary ccRCC cells and primary ccRCC cells vs adjacent normal renal tissues. 7 We also studied the tumour suppressor role of GSTM3 in the progression of ccRCC and a polymorphism rs1332018 which was significantly associated with the postoperative prognosis of ccRCC. 8 In the current study, we report a novel SNP in ccRCCrs1055259 in the 3 0 untranslated region (UTR) of GSTM3 significantly reduced the ccRCC risk and influence the binding of miR-556 to the 3 0 UTR of GSTM3. This might be the potential mechanism of rs1055259 impact the renal carcinoma risk. Table 1 . Cases and controls were frequency matched on gender and healthy controls were older than patients. All the patients were pathologically confirmed and signed the informed consent. 
| MATERIALS AND METHODS

| Study population and postoperative Follow-up
| Blood samples collection and ccRCC cells primary culture
Ethylene diamine tetraacetic acid (EDTA) anticoagulated peripheral blood samples were collected from patients before nephrectomy and healthy controls. Genomic DNA was extracted using a RelaxGene Blood DNA System (TIANGEN biotech, Beijing, China)
according to the manufacturer's instruction. The fresh surgical specimens of ccRCC from 17 patients were harvested and immediately immersed in ice-cold PBS containing 1% penicillin/streptomycin and 0.5% glutamine (Beyotime, Shanghai, China). Primary cell culture was performed within 60 min after surgery as previously described. 7 As a variation of phenotype might occur at higher passages, we chose the ccRCC cultures at the fourth passage for functional experiments.
| SNP selecting and genotyping
We selected 5 SNPs by analysing GSTM3-related Han Chinese data from 1000 Genome Project resources (http://www.1000genomes. org). The candidate SNPs should meet these criteria: (1) the minor allele frequency (MAF) > 0.05; (2) r 2 < .80 ( Figure 1A) ; (3) at the 3 0 UTR of GSTM3. The significant SNP rs1055259 is located at a miR-556 binding site, with predicted proximal transcriptional regulatory potential (http://rsnp.psych.ac.cn/) (http://snpinfo.niehs.nih.gov/ cgi-bin/snpinfo/ snpfunc.cgi). rs1537236, rs3814309, rs1109138 and rs5776997 were also predicted as functional SNPs, which seated in other miRNA binding sites.
All SNPs were genotyped using matrix-assisted laser desorption Biotechnology, Shanghai, China) ( 
| Bioinformatic prediction of candidate SNPs
The SNP-flanking region RNA was online analysed using RNAfold 
| Quantitative real-time PCR analysis of miR-556
The expression level of miR-556 was detected using RNA-tailing and primer-extension real-time PCR according to the instructions of All-in-One miRNA Detection Kit (Fulengen, Guangzhou, China). miR-556 forward primer: 5 0 -AGAAGCAATTCTAGAAG-3 0 ; the reverse primer was miRNA universal adaptor PCR primer (Fulengen).
| Luciferase reporter assay
To evaluate the binding of miR-556 to 3 0 UTR of GSTM3, 3 reporter constructs carrying 2 copies of rs1055259-A allele, G allele or mutant sequences at the 3 0 UTR of luciferase gene were created.
Firstly, three~100-bp DNA sequences centred at rs1055259 (A or G allele) or mutant sequence were synthesized; then, 2 tandem copies of these sequences were cloned into pGL-3 Basic vector (Promega, Madison, WI, USA) using restriction enzyme sites-Sal I and BamH I.
The schematic diagram for vector construction is shown in Figure 2A . Six replicates for each group and the experiment were repeated at least 3 times. *P < .05, ns: non-significant compared between treatment group and control group USA) using Dual-luciferase Reporter Assay System (Promega) according to the instruction of manufactures. Results were represented as relative luciferase activity to pRL-TK.
| Measurement of reactive oxygen species (ROS) activity
ROS activity was measured in ccRCC cells from 17 patients with different rs1055259 genotypes (AA = 8, AG = 6, GG = 3) using DCFH-DA (Beyotime). It is an oxidation-sensitive fluorescence probe.
Cells were seeded in 6-well plates (1 9 10 5 ) and incubated with DCFH-DA in 37°C for 20 minutes. After washing with PBS, the nuclei were stained by DAPI (Beyotime). The cells were imaged on a Carl
Zeiss LSM880 laser scanning confocal microscope (Carl zeiss, Jena, Germany). Quantitative analysis of DCF fluorescence was conducted with Image Pro Plus 6.0 (Media Cybernetics, Silver Spring, MD, USA).
| Cell proliferation and invasion assay
Proliferation of ccRCC cells was determined using cell counting kit-8 away, and the invaded cells were stained with ponceau. Finally, the images were captured with a phasecontrast microscope (Olympus IX51, Tokyo, Japan). The invaded cells were quantified by counting 10 independent visual fields to determine the average invasion ratio.
Each assay was performed in triplicate. with A allele (adjusted OR = 0.72, 95% CI = 0.51-0.98, P = .040) ( with an increased miR-556 level by 3.03-fold simultaneously (Figure 3E-G) . For in vitro study, CoCl2 is commonly used to mimic a hypoxic environment in inner area of solid tumor. These data suggested that the malignant progression of renal carcinoma might inhibit the GSTM3 expression via increasing miR-556 level.
| Statistical analysis
F I G U R E 4
Reactive oxygen species (ROS) activity in ccRCC primary cells with different genotype of rs1055259. (A) Representative confocal-microscopy graphs of ROS activity in rs1055259 AA, AG and GG cells incubated with DCFH-DA (it could be ROS-oxidized to DCF, which presented green fluorescence). (B) Quantitative analysis of ROS activity in different group. The experiment was repeated at least 3 times. Data were presented as mean AE S.D. Scale bar: 50 lm. *P < .05, **P < .01
| rs1055259 variant reduced ROS activity
To evaluate the biological effect of rs1055259 on GSTM3 activity in vivo, we measured the ROS activity in ccRCC cells from patients with AA, AG and GG genotypes. As shown in Figure 4 , the GSTM3 activity was obviously different among patients with rs1055259 AA, AG and GG genotypes. The average ROS activity was highest in AA genotype, followed by AG and then lowest in GG genotype (2067.43 AE 117.76, 1310.65 AE 162.07 and 708.51 AE 79.34, respectively). This result suggested that rs1055259 variant, which was related with GSTM3 expression, indeed reduced ROS activity.
| rs1055259 variant suppressed the proliferation and invasion of ccRCC cells
It has been proven that GSTM3 is a tumour suppressor in ccRCC. | 3013 transcriptional regulation. According to the evidences shown in Figure 2 and 3 , rs1055259 A > G change increased the transcriptional activity, affected the miRNA binding and enhanced GSTM3 expression. To the best of our knowledge, the functional polymorphismrs1055259 has not been reported in other investigations. This is the first study to demonstrate the potential function of rs1055259 in GSTM3 expression and ccRCC development.
Another intriguing finding was that rs1055259 might be related to ROS activity, by fine tuning the GSTM3 expression. As is known to all, cytosolic glutathione S-transferases (GSTs) are members of phase II metabolic isozymes super family. They protect cells against electrophilic damage via catalysing the conjugation of ROS and glutathione. 9,10 Dysfunction of GSTs has been implicated in the progression of RCC, because of the defect of anti-oxidant capacity.
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Our study showed that the ROS activity (reflected by DCF immunofluorescence) was highest in ccRCC cells with rs1055259 AA genotype than AG and GG genotypes. However, rs1055259 variant was proven associated with GSTM3 expression. Namely rs1055259 might modulate the ROS activity via elevating GSTM3 expression.
Thus, the subjects carrying A allele are more prone to ccRCC because their ROS activity tends to be higher against those with G allele.
Generous studies revealed that epigenetic inactivation of GSTM3 or low GSTM3 expression correlated with tumorigenesis and advanced AJCC stage of cancer. 12, 13 These reports, together with our previously study, 7 suggested that GSTM3 might function as a suppressor in tumour progression. Elevated ROS activity also played an important role in cancer cell survival and development.
14 Thus, we detected the relationship between rs1055259, ROS activity and ccRCC development. In transwell assay, we found that the invasion cells per visual field were the most in AA group and then AG and GG groups. After ROS scavenger-NAC was added, the numbers of invasion cells were obviously decreased. Similarly, the cell viability in AA group was higher than AG and GG group. With NAC+, the cell viability was notably reduced by more than 30%. targets of ROS. [15] [16] [17] Several studies revealed that unregulated and augmented ROS could initiate redox-linked signalling responses and irreversible injuries in RCC. 18, 19 Moreover, changes of cellular redox balance in RCC might also be associated with alterations of glutathione S-transferase (GST) expression and phenotype. 18 Therefore, it is necessary to clarify underlying mechanisms between the important anti-oxidant enzyme-GSTM3 in ccRCC, 7, 8 thiol level, ROS activity and redox signalling responses. The further investigations should be carried out.
In summary, we demonstrated that rs1055259 in GSTM3 3 0 UTR affected the miR-556 binding and GSTM3 expression in ccRCC for the first time. The G allele of rs1055259 predisposes hosts to downregulated GSTM3 and reduced ccRCC susceptibility. rs1055259 variant genotype was a significant genetic protect factor. These findings will be helpful in diagnosis prediction and surveillance of ccRCC, as well as in the advancement of targeted therapy for this renal malignancy. The current study also indicated that it warranted further investigations of GSTM3 expression in ccRCC.
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